Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) – a group of bone marrow disorders characterized by […]

ZenaTech’s Zena AI Division for Advanced AI-Driven Drone Solutions for US Defense and Homeland Security to be Based in Baton Rouge, Louisiana

ZenaTech's Zena AI Division for Advanced AI-Driven Drone Solutions for US Defense and Homeland Security to be Based in Baton Rouge, Louisiana GlobeNewswire October 23, 2025 VANCOUVER, British Columbia, Oct. 23, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI (Artificial Intelligence) drones,

The 60-Day XRP Countdown: Analysts Predict a New Crypto Wealth Wave as AI-Driven Blockchain Finance Expands

The 60-Day XRP Countdown: Analysts Predict a New Crypto Wealth Wave as AI-Driven Blockchain Finance Expands NB HASH unveils an AI-powered hashrate ecosystem that transforms blockchain computation into real-world digital income — aligning with XRP's deflationary momentum and the global shift toward tokenized finance. GlobeNewswire October 23, 2025 New York City, NY, Oct. 23, 2025

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication GlobeNewswire October 23, 2025 TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma“), a biopharmaceutical company dedicated to building a portfolio of

Tourism Returns to Israel: Visitors Come Back Amid Cease-Fire and Recovery

Two years after the devastatingHamas assault on October 7, 2023, Israel's tourism industry is showing strong signs of revival, according to America Israel Tours®(AIT), one of the U.S.'s leading Holy Land travel providers. Hotels, tourist sites, and historic markets are reopening as international visitors return, bringing both economic recovery and renewed hope to the country.

Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules

$2.7 million upfront with up to an additional $5.4 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants Genprex, Inc.(“Genprex” or the “Company”) (NASDAQ:GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has entered into definitive agreements for

Typeform Launches AI Engagement Platform to Turn Forms Into Workflows

New capabilitiesunite form creation, automation, and analytics to help businesses capture, connect, and convert in one place Typeform today launched its AI engagement platform, marking a major step in the company's evolution from form builder to engagement ecosystem. Built on insights from over 1 billion anonymized responses, the platform unites forms, automation, and data to

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

(NASDAQ:ECOR), ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third quarter ended September 30, 2025, after the close of the market on Wednesday, November 5, 2025. Management will host a webinar at 4:30 PM

Access Ready Strategic Joins the Consortium for Constituents with Disabilities (CCD) and Other Organizations on Vital Policy and Public Interest Positions

Many Groups and Organizations respond to Policy Issues The recent rapid approach to policy changes at the Federal and State levels are prompting detailed responses by the effected communities through the organizations that represent their collective interests. Access Ready Strategic questions those proposing such sweeping changes. “What if you're wrong? What if your policies and

Scroll to Top